Risk Prediction Models, Guidelines, Special Populations, and Outcomes

Abstract

This chapter will discuss risk prediction models for aortic valve replacement, review of the most recent guidelines regarding aortic stenosis, specific patient populations with aortic stenosis, and the valve academic research consortium (VARC) consensus regarding standardized endpoint definitions for transcatheter aortic valve replacement (TAVR).

Keywords

Risk prediction models for aortic valve replacement Guidelines for aortic stenosis Valve academic research consortium (VARC) Transcatheter aortic valve replacement (TAVR) Aortic stenosis during pregnancy 

References

  1. 1.
    Mack MJ. Risk assessment for valvular heart disease. Valvular heart disease. A companion to Braunwald’s heart disease. 4th ed. Philadelphia: Elsevier; 2013.Google Scholar
  2. 2.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RRA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JM. 2014 ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2014. doi: 10.1016/j.jacc.2014.02.536.Google Scholar
  3. 3.
    O’Brien SM, Shaian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand ST, DeLong ER, Shewan CM, Dokholyan RS, Eterson ED, Edwards FH, Anderson RP, The Society of Thoracic Surgeons. Cardiac surgery risk models: part 2-isolated valve surgey. Ann Thorac Surg. 2008;88(1):S23–42.CrossRefGoogle Scholar
  4. 4.
    Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63:747–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Marshall G, Grover FL, Henderson WG, et al. Assessment of predictive models for binary outcomes: an empirical approach using operative death from cardiac surgery. Stat Med. 1994;13:1501–11.PubMedCrossRefGoogle Scholar
  6. 6.
    Hannan EL, Kilburn Jr H, O’Donnell JF, et al. Adult open heart surgery in New York State: an analysis of risk factors and hospital mortality rates. JAMA. 1990;264:2768–74.PubMedCrossRefGoogle Scholar
  7. 7.
    Grover FL, Shroyer AL, Hammermeister KE. Calculating risk and outcome: the veterans affairs database. Ann Thorac Surg. 1996;62:S6–11.PubMedCrossRefGoogle Scholar
  8. 8.
    O’Connor GT, Plume SK, Olmstead EM, et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992;85:2110–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3–12.PubMedGoogle Scholar
  10. 10.
    Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J. 2009;30:74–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Leontyev S, Walther T, Borger MA, et al. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg. 2009;87:1440–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Kappetein AP, Head SJ. Predicting prognosis in cardiac surgery: a prophecy? Eur J Cardiothorac Surg. 2012;41:732–3.PubMedCrossRefGoogle Scholar
  14. 14.
    Roques F, Nashef SAM, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg. 1999;15:816–23.PubMedCrossRefGoogle Scholar
  15. 15.
    Roques F, Michel P, Goldstone AR, et al. The logistic EuroSCORE. Eur Heart J. 2003;24:881–2.PubMedCrossRefGoogle Scholar
  16. 16.
    Chalmers J, Pullan M, Fabri B, et al. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg. 2013;43:688–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Dewey T, Brown D, Ryan WH, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008;135:180–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Conradi L, Seiffert M, Treede H, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg. 2012;143:64–71.PubMedCrossRefGoogle Scholar
  19. 19.
    Online STS Risk Calculator. < http://riskcalc.sts.org.
  20. 20.
    Shahian DM, He X, Jacobs JP. The society of thoracic surgeons isolated Aortic Valve Replacement (AVR) composite score: a report of the STS quality measurement task force. Ann Thorac Surg. 2012;94:2166–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Rankin SJ, He X, O’Brien SM. The society of thoracic surgeons risk model for operative mortality after multiple valve surgery. Ann Thorac Surg. 2013;95:1484–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Ambler G, Omar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation. 2005;112:224–31.PubMedCrossRefGoogle Scholar
  23. 23.
    Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg. 2004;77:1966–77.PubMedCrossRefGoogle Scholar
  24. 24.
    Ranucci M, Castelvecchio S, Menicanti L, et al. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the Law of Parsimony. Circulation. 2009;119:3041–3.CrossRefGoogle Scholar
  25. 25.
    Ranucci M, Castelvecchio S, Conte M. The easier, the better: age, creatinine, ejection fraction score for operative mortality risk stratification in a series of 29,659 patients undergoing elective cardiac surgery. J Thorac Cardiovasc Surg. 2011;142:581–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Ariyaratne TV, Billah B, Yap CH, et al. An Australian risk prediction model for determining early mortality following aortic valve replacement. Eur J Cardiothorac Surg. 2011;39:815–21.PubMedCrossRefGoogle Scholar
  27. 27.
    Gummert JF, Funkat A, Osswald B, et al. EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol. 2009;98:363–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Kötting J, Schiller W, Beckmann A, et al. German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg. 2013;43:971–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Thomas M, Schymic G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124(4):425–33.PubMedCrossRefGoogle Scholar
  30. 30.
    Mack MJ, Brennan M, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, Hewitt K, Shewan C, Michaels J, Christensen B, Christian A, O’Brien S, Holmes D. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–77.PubMedCrossRefGoogle Scholar
  31. 31.
    ESC 2014 Late-Breaking Clinical Trial: is TAVI the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE 2 registry. Presented by E Van Belle on September 2.Google Scholar
  32. 32.
    Allende R, Webb JG, Munoz-Garcia AJ, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. Eur Heart J. 2014;35(38):2685.PubMedCrossRefGoogle Scholar
  33. 33.
    Williams M, Kodali SK, Hahn RT, et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis. Insights from the PARTNER trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol. 2014;63:1522–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Lucon A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. Study from the FRANCE 2 Registry. Circ Cardiovasc Interv. 2014;7(2):240–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Bedogni AL, de Marco F, et al. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the corevalve revalving system. A multicenter registry. Circulation. 2013;128:2145–53.PubMedCrossRefGoogle Scholar
  36. 36.
    Mok M, Nombela-Franco L, Dumont E, Urena M, DeLarochellière R, Doyle D, Villeneuve J, Côté M, Ribeiro HB, Allende, Laflamme J, DeLarochellière H, Laflamme L, Amat-Santos I, Pibarot P, Maltais F, Rodés-Cabau J. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation. Insights on clinical outcomes, prognostic markers, and functional status changes. J Am Coll Cardiol Intv. 2013;6(10):1072–108.CrossRefGoogle Scholar
  37. 37.
    Barbanti M, Binder RK, Dvir D, Tan J, Freeman M, Thompson CR, Cheung A, Wood DA, Leipsic J, Webb JG. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014. doi: 10.1002/ccd.25512 [Epub ahead of print].Google Scholar
  38. 38.
    One-Year TAVR Mortality and Stroke Data Reassures. Medscape. Apr 01, 2014.Google Scholar
  39. 39.
    Vahanian A, Alfieri O, Andreotti F, et al. Guidelines for the management of Valvular Heart Disease. Eur Heart J. 2012;33:2451–96.PubMedCrossRefGoogle Scholar
  40. 40.
    Lao TT, Sermer M, MaGee L, et al. Congenital aortic stenosis and pregnancy—a reappraisal. Am J Obstet Gynecol. 1993;169:540–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Stout KK, Krieger EV. Valvular heart disease in pregnancy. Valvular heart disease. A companion to Braunwald’s heart disease. 4th ed. Philadelphia: Elsevier; 2013.Google Scholar
  42. 42.
    Tzemos N, Silversides CK, Colman JM, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J. 2009;157:474–80.PubMedCrossRefGoogle Scholar
  43. 43.
    Easterling TR, Chadwick HS, Otto CM, et al. Aortic stenosis in pregnancy. Obstet Gynecol. 1988;72:113–8.PubMedGoogle Scholar
  44. 44.
    Arias F, Pineda J. Aortic stenosis and pregnancy. J Reprod Med. 1978;20:229–32.PubMedGoogle Scholar
  45. 45.
    Shime J, Mocarski EJ, Hastings D, et al. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol. 1987;156:313–22.PubMedCrossRefGoogle Scholar
  46. 46.
    Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int J Cardiol Cardiol. 2005;98:179–89.CrossRefGoogle Scholar
  47. 47.
    Brian Jr JE, Seifen AB, Clark RB, et al. Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth. 1993;5:154–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Yap SC, Drenthen W, Pieper PG, et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126:240–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46:1243–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Lao TT, Adelman AG, Sermer M, et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol. 1993;100:1141–2.PubMedCrossRefGoogle Scholar
  52. 52.
    Sreeram N, Kitchiner D, Williams D, et al. Balloon dilatation of the aortic valve after previous surgical valvotomy: immediate and follow up results. Br Heart J. 1994;71:558–60.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J. 1993;70:544–5.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Samarendra P, Mangione MP. Aortic stenosis and Perioperative risk with Noncardiac surgery. J Am Coll Cardiol. 2015;65:29–302.Google Scholar
  55. 55.
    Santlebury DC, Geske JB, Nishimura RA. Limitations of Doppler echocardiography in the evaluation of serial stenoses. Circ Cardiovasc Imag. 2013;6:850–2.CrossRefGoogle Scholar
  56. 56.
    Zilberszac R, Gabriel H, Schemper M, Zahler D, Czerny M, Maurer G, Rosenhek R. Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol. 2013;61(14):1489–95.PubMedCrossRefGoogle Scholar
  57. 57.
    Grewal HK, Bansal M, Kasliwal RR. Complex issues in aortic valve diseases. In: Valvular heart disease CSI.ORG.IN. 2014.Google Scholar
  58. 58.
    Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57(3):253–69.PubMedCrossRefGoogle Scholar
  59. 59.
    Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–54.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  1. 1.Department of Cardiovascular DiseaseBaylor Scott & White HealthPlanoUSA
  2. 2.Department of Cardiovascular MedicineBeaumont Health, Oakland University/William Beaumont School of MedicineRoyal OakUSA

Personalised recommendations